Eli Lilly

Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers. Read more

70,811 Followers on Owler
70,811 Followers on Owler
70,811 Followers on Owler
70,811 Followers on Owler

Eli Lilly

Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers. Read more

David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

71/100

Founded:

1876

Status:

PublicIndependent CompanyNYSELLY

ELI LILLY TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

AbbVie is one of Eli Lilly's top rivals. AbbVie is a Public company that was founded in 2013 in North Chicago, Illinois. Like Eli Lilly, AbbVie also works within the Pharmaceuticals industry. Compared to Eli Lilly, AbbVie has 8,320 more employees.

Amgen is seen as one of Eli Lilly's biggest rivals. Amgen was founded in 1980 in Thousand Oaks, California. Amgen competes in the Biotechnology industry. Amgen generates $624.2M more revenue than Eli Lilly.

AstraZeneca is one of Eli Lilly's top competitors. AstraZeneca was founded in 1999, and its headquarters is in Cambridge, England. Like Eli Lilly, AstraZeneca also operates in the Pharmaceuticals sector. AstraZeneca has 37,420 more employees than Eli Lilly.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Baxter a competitor of Eli Lilly?

Eli Lilly Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$24.5B

Eli Lilly's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 29.1B. Over the last four quarters, Eli Lilly's revenue has grown by 23.8%. Specifically, in Q1 2021's revenue was $6.8B; in Q4 2020, it was $7.4B; in Q3 2020, it was $5.7B; in Q2 2020, Eli Lilly's revenue was $5.5B.

Eli Lilly Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Prevail Therapeutics, Inc.

Dec 2020

Source »
$1B
Prevail Therapeutics is a biotechnology company that develops and commercializes novel therapies for the treatment of neurodegenerative disorders.
Disarm Therapeutics, Inc.

Oct 2020

Source »
$135M
Disarm Therapeutics is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders.
Dermira, Inc.

Jan 2020

Source »
$1.1B
Dermira develops and commercializes therapeutics for the treatment of dermatological diseases.
Loxo Oncology, Inc.

Jan 2019

Source »
$8B
Loxo Oncology develops and markets genomic medicines for the treatment of cancer.

-

Pre-clinical Program, TRPA1 Antagonists, Hydra

Dec 2018

Source »
undisclosed
-

These are all the companies that Eli Lilly has acquired. Eli Lilly has acquired 24 companies and its latest acquisition was Prevail Therapeutics, Inc. in Dec 2020. Prevail Therapeutics is a biotechnology company that develops and commercializes novel therapies for the treatment of neurodegenerative disorders.

Eli Lilly Funding History

No recent funding data found related to Eli Lilly

Eli Lilly Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$20M
May 09, 2021
Investment Fund
-
Jaguar Gene Therapy is an Illinois-based biotech company that researches and develops gene and related illness therapies for the treatment of genetic and autistic disorders.
$139M
Apr 12, 2021
Series B
-
Amphista is a UK-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
$53M
Mar 15, 2021
Series B
-
DTx Pharma is a biotechnology company that researches and develops RNA-based therapies for the treatment of rare diseases.
$100M
Feb 28, 2021
Series B
-
Evox is a biotechnology company that develops and commercializes exosome-based therapeutics for the treatment of genetic diseases.
$95.4M
Feb 17, 2021
Series C
-

These are all the companies that Eli Lilly has invested in. Eli Lilly has invested 24 companies and its latest investment was Prevail Therapeutics, Inc. in Dec 2020. Prevail Therapeutics is a biotechnology company that develops and commercializes novel therapies for the treatment of neurodegenerative disorders.

Eli Lilly News

May 11, 2021MarketScreener

enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India

(marketscreener.com) May 11, 2021 Corporate Relationship Department National Stock Exchange...https:/... See more »
May 11, 2021FiercePharma

With lower COVID-19 cases expected this summer, Eli Lilly to welcome all employees back to Indianapolis HQ

With lower COVID-19 cases expected this summer, Eli Lilly to welcome all employees back to Indianapol... See more »
May 11, 2021BW BUSINESSWORLD

Dr Reddy's Inks Licensing Pact With Eli Lilly For COVID-19 Treatment Drug

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing a... See more »
May 10, 2021TechCrunch

Indy VC firm Sixty8 Capital launches $20M fund aimed at underrepresented founders

It is clear that Black, women, Latinx and LGBTQ+ startup founders face an uphill battle when it comes... See more »
May 10, 2021Pharmafile

Eli Lilly to collaborate with diabetes tech companies on insulin pen

Eli Lilly has signed strategic international agreements with four companies - Dexcom, Glooko, myDiabb... See more »
May 10, 2021MarketScreener

Eli Lilly signs deals to boost supply of COVID-19 treatment in India

(marketscreener.com) BENGALURU -Eli Lilly and Co said on Monday it had signed licensing agreements wi... See more »
May 10, 2021Inside Indiana Business

Lilly Plans for Fully Staffed HQ by Mid-July

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has laid out its timeline for the return of its offi... See more »

Eli Lilly Blogs

Eli Lilly Press Releases

April 16, 2021Cision Canada

Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

/CNW/ - On April 8, 2021, Eli Lilly and Company and Incyte announced the results of COV-BARRIER, a Ph... See more »
April 1, 2021PR Newswire

Lilly to Host Sustainability Webcast to Provide Overview of Environmental, Social and Governance (ESG) Efforts

INDIANAPOLIS, April 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will host a webcast for... See more »
March 29, 2021PR Newswire

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19

INDIANAPOLIS and SAN FRANCISCO and LONDON, March 29, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE... See more »
March 10, 2021PR Newswire

Lilly Announces Details of Presentations at 2021 American Association for Cancer Research (AACR)

INDIANAPOLIS, March 10, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that d... See more »
March 9, 2021PR Newswire

Data from Lilly at International Conference on Alzheimer's & Parkinson Diseases 2021 (AD/PD 2021) to Showcase Clinical Advances in Alzheimer's Disease Research

INDIANAPOLIS, March 9, 2021 /PRNewswire/ -- New data from 10 studies will be presented by Eli Lilly a... See more »
February 25, 2021StreetInsider

Welldoc and Lilly collaborate to integrate BlueStar app capabilities into Lilly's connected insulin solutions

COLUMBIA, Md. and INDIANAPOLIS, Feb. 25, 2021 /PRNewswire/ -- Welldoc, Inc., and Eli Lilly and Com... See more »
January 14, 2021centralcharts

Gabrielle Sulzberger Elected to Lilly Board of Directors

Gabrielle Sulzberger Elected to Lilly Board of Directors PR Newswire INDIANAPOLIS, Jan. 14, 2021 INDI... See more »

Eli Lilly Videos

Social Media

Eli Lilly Headquarters

Lilly Corporate Center

Indianapolis, Indiana46285

1-317-276-2000

Driving Directions »

Trending Companies

Eli Lilly Summary

ABOUT

Overview

Eli Lilly and Company (NYSE: LLY) manufactures and sells pharmaceutical products for health care professionals, patients, and consumers. Is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana. The company also ...

CEO

Eli Lilly's Chairman & CEO, David A. Ricks, currently has an approval rating of 71%. Eli Lilly's primary competitors are AbbVie, Amgen & AstraZeneca.

Website

lilly.com

Frequently Asked Questions about Eli Lilly

  1. When was Eli Lilly founded?

    Eli Lilly was founded in 1876
  2. Who is Eli Lilly's CEO?

    Eli Lilly's CEO is David A. Ricks
  3. How much revenue does Eli Lilly generate?

    Eli Lilly generates $24.5B in revenue
  4. How much funding does Eli Lilly have?

    Eli Lilly has historically raised $0 in funding
  5. Where is Eli Lilly's headquarters?

    Eli Lilly's headquarters is in Indianapolis Indiana, USA
  1. How many employees does Eli Lilly have?

    Eli Lilly has 38,680 employees
  2. What sector does Eli Lilly operate in?

    Eli Lilly is in Pharmaceuticals
  3. Who are Eli Lilly's competitors?

    Eli Lilly's top competitors are AbbVie, Amgen, AstraZeneca
  4. Who has Eli Lilly invested in?

    Eli Lilly's has invested in companies such as Sixty8 Capital, Jaguar Gene Therapy, Amphista